Treatment Guidelines Title Format; MMWR /Medscape free CME credit on the updated 2020 latent TB infection treatment guidelines. external icon Registration may be required. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
Comprehensive guidelines for treatment of latent tuberculosis infection (LTBI) among persons living in the United States were last published in 2000 (American Thoracic Society. CDC targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221–47).
The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of ...
The American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America jointly sponsored the development of this guideline for the treatment of drug-susceptible tuberculosis, which is also endorsed by the European Respiratory Society and the US National Tuberculosis Controllers Association.
The guidelines provide recommendations on the clinical and public health management of tuberculosis (TB) in children and adults in well-resourced settings. The guidelines provide evidence-based recommendations that have been developed using GRADE (Grading of Recommendations Assessment, Development, and Evaluation) methodology.
[Guideline] Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, et al. Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020 Feb 14. 69 (1):1-11. . Hackethal V. Short TB Therapies Fail in Larger, Longer Trials.
Latent TB Infection : Updated and consolidated guidelines for programmatic management 15 February 2018; 2017. Guidelines for treatment of drug-susceptible tuberculosis and patient care (2017 update) 22 March 2017; 2016. The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: Interim policy guidance
Tuberculosis Treatment Guidelines. 2303 Southeast Military Drive • San Antonio, Texas 78223. 1-800-TEX-LUNG • www.heartlandntbc.org. Please note:
Prevention and Control of Tuberculosis in Correctional and Detention Facilities; Guidelines for Preventing the Transmission of M. TB in Health care Settings; Investigation of Contacts of Persons with Infectious TB; Epidemiology of Pediatric Tuberculosis in the United States; Targeted Tuberculosis Testing and Treatment of Latent Tuberculosis ...
Note: this table is an except from Treatment of Drug-Susceptible Tuberculosis external icon and cites supporting information available in the complete guidelines. Highlights from the 2016 Treatment of Drug-Susceptible Tuberculosis Guidelines